BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness
Go back to BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National Preparedness| Regeneron (NASDAQ: REGN) | Delayed: 852.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $852.03 | 52 Week High | $592.36 | |||
| Open | $852.03 | 52 Week Low | $325.35 | |||
| Day High | $852.03 | P/E | 223.63 | |||
| Day Low | $852.03 | EPS | $3.81 | |||
| Volume | 61 | |||||

